Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities-Reference-Cited by-同舟云学术

Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities

Published:2011-08-12 Issue:1 Volume:25 Page:65-74
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Boiocchi Leonardo,Orazi Attilio,Ghanima Waleed,Arabadjief Melissa,Bussel James B,Geyer Julia Turbiner

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2011128.pdf

Reference41 articles.

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386–2393.

2. Cines DB, Bussel JB . How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244–2251.

3. Bussel JB . Traditional and new approaches to the management of immune thrombocytopenia: issues of when and who to treat. Hematol Oncol Clin North Am 2009;23:1329–1341.

4. Hasan A, Michel M, Patel V, et al. Repeated courses of rituximab in chronic ITP: three different regimens. Am J Hematol 2009;84:661–665.

5. Aleem A, Alaskar AS, Algahtani F, et al. Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients. Int J Hematol 2010;92:283–288.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute;Blood Cells, Molecules, and Diseases;2024-09

2. Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis;Cell;2023-09

3. Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations;Hematology Reports;2022-09-09

4. Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia;British Journal of Haematology;2022-06-14

5. Exploring the Potential of Eltrombopag: Room for More?;Frontiers in Pharmacology;2022-05-23